Skip to Content

THC Farmaceuticals Inc Stock Quote CBDG

Rating as of

Morningstar's THC Farmaceuticals Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - CBDG

Company Profile - CBDG

Business Description

THC Farmaceuticals Inc is a clinical stage biotechnology company. It specializes in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology, and other medical disciplines.

1000 Newbury Road, Suite 138 B
Thousand Oaks, CA, 91320
T +1 805 978-5609
Industry Biotechnology
Most Recent Earnings Jun 30, 2018
Fiscal Year End Sep 30, 2022
Stock Type Distressed